01Impact factor
Impact factor of Neurodegenerative Diseases (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Neurodegenerative Diseases published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Clinical Neurologyrank 181 of 297 journals
- Neurosciencesrank 254 of 321 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Neurodegenerative Diseases
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Neurodegenerative Diseases is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Neurodegenerative Diseases?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Neurosciences accept papers in a median of 50 days.
APC waivers and discounts for Neurodegenerative Diseases
Karger: waiver or discount for low and lower-middle income countries; percentages are not published.
02Funders
Who funds research published in Neurodegenerative Diseases
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
03Indexing
Indexing of Neurodegenerative Diseases
- ISSN
- 1660-2854
- eISSN
- 1660-2862
- Publisher
- S. Karger AG
- Country
- Switzerland
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Clinical Neurology, Neurosciences
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Neurodegenerative Diseases
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Neurodegenerative Diseases accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Compare your title and abstract with the papers it has published; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Neurodegenerative Diseases is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05What it publishes
What Neurodegenerative Diseases publishes: real papers
06Published papers
Papers published in Neurodegenerative Diseases
Papers from the publication records ScholarsColab tracks, with their year and citations. Author names are not shown.
07Reviewer comments
Reviewer comments and rejection reasons for Neurodegenerative Diseases
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Neurodegenerative Diseases, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds08Similar journals
Journals similar to Neurodegenerative Diseases
Journals that publish the closest work to the papers above, from the indexing lists:
- PeerJSCIEScopusJCR 202419 similar papers
- PLoS ONESCIEScopusJCR 202465 similar papers
- Frontiers in NeurologySCIEScopusJCR 202417 similar papers
- Neuropsychiatric Disease and TreatmentSCIEScopusJCR 20241 similar paper
- Frontiers in Molecular NeuroscienceSCIEScopusJCR 20241 similar paper
- Neuroscience LettersSCIEScopusJCR 20241 similar paper
09Same subject
Clinical Neurology journals with a similar impact factor*
The journals next to Neurodegenerative Diseases when the 286 journals of Clinical Neurology in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 177 | Alzheimer Disease & Associated Disorders | 1.60 | SCIE | Subscription |
| 178 | Pain Management | 1.57 | ESCI | Subscription |
| 179 | Cerebrovascular Diseases | 1.57 | SCIE | Subscription |
| 180 | Bipolar Disorders | 1.57 | SCIE | Subscription |
| 182 | Clinical Parkinsonism & Related Disorders | 1.49 | ESCI | Fully open access |
| 183 | Neurointervention | 1.47 | ESCI | Fully open access |
| 184 | Journal of Korean Neurosurgical Society | 1.46 | SCIE | Fully open access |
| 185 | Neurochirurgie | 1.45 | SCIE | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Neurodegenerative Diseases right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,240 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
10Questions
Frequently asked questions
What is the impact factor of Neurodegenerative Diseases?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Neurodegenerative Diseases is 1.54: papers it published in the two previous years were cited 1.54 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Neurodegenerative Diseases?
The h-index of Neurodegenerative Diseases is 80 (October 2026): 80 of its papers have each been cited at least 80 times. Its i10-index is 698.
What is the quartile of Neurodegenerative Diseases?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Neurodegenerative Diseases is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Neurodegenerative Diseases indexed in Scopus?
Yes. Neurodegenerative Diseases appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Neurodegenerative Diseases an SCIE journal?
Yes. Neurodegenerative Diseases is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Neurodegenerative Diseases in Journal Citation Reports (JCR)?
Yes. Neurodegenerative Diseases is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
How many papers published in Neurodegenerative Diseases does ScholarsColab track?
We track 1 paper published in Neurodegenerative Diseases in 2016, cited 54 times in total, with a median of 54 citations per paper.
Does Neurodegenerative Diseases offer an APC waiver?
Neurodegenerative Diseases follows the policy of Karger: waiver or discount for low and lower-middle income countries; percentages are not published. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Neurodegenerative Diseases?
0% of 66 recent research articles in Neurodegenerative Diseases name a funder.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Electrochimica Acta
- Heliyon
- Journal of Hazardous Materials
- Tetrahedron
- Langmuir
- Journal of Clinical Oncology
- Journal of Materials Science
- European Heart Journal
- American Journal of Cardiology
- Physical Review
- Remote Sensing
- Journal of Hepatology
- Gastroenterology
- Tetrahedron Letters
Browse all journals: indexing, impact factor and reviewer comments →